These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 34878401)

  • 1. [Tackling diagnostic odysseys: a priority shared by Filnemus and AFM-Téléthon].
    André C; Pisella L; Cottet C; Segovia-Kueny S; Molon A; Moreno-Elgard P; Bellot MC; Attarian S
    Med Sci (Paris); 2021 Nov; 37 Hors série n° 1():56-59. PubMed ID: 34878401
    [No Abstract]   [Full Text] [Related]  

  • 2. [Renewal of Filnemus: ambitious goals for 2019-2023].
    Attarian S; Salort-Campana E
    Med Sci (Paris); 2019 Nov; 35 Hors série n° 2():5-6. PubMed ID: 31859622
    [No Abstract]   [Full Text] [Related]  

  • 3. [From the first french Telethon to the rare diseases act: the role of AFM].
    Tiennot-Herment L
    Arch Pediatr; 2010 Jun; 17(6):699. PubMed ID: 20654848
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diseases of the motor system--a review].
    Edström L; Conradi S; Henriksson KG; Osterman PO; Stålberg E
    Lakartidningen; 1989 Feb; 86(7):531-4. PubMed ID: 2918791
    [No Abstract]   [Full Text] [Related]  

  • 5. [Neurogenic, medullary, cerebellar, myogenic syndrome. Diagnostic orientation and management].
    Lamy C; de Recondo J
    Rev Prat; 1990 Sep; 40(19):1784-90. PubMed ID: 2218339
    [No Abstract]   [Full Text] [Related]  

  • 6. [Walking, detection of pathology].
    Berquin P; Dolhem P
    Arch Pediatr; 1998; 5 Suppl 2():156s-157s. PubMed ID: 9759245
    [No Abstract]   [Full Text] [Related]  

  • 7. [Towards an harmonization of diagnosis by NGS of neuromuscular diseases - Actions of the Molecular Genetics sub-group of FILNEMUS].
    Perrin A; Latour P; Procaccio V; Jardel C; Cérino M; Bonne G; Salort-Campana E; Urtizberea JA; Pouget J; Krahn M; Cossée M
    Med Sci (Paris); 2018 Nov; 34 Hors série n°2():20-22. PubMed ID: 30418140
    [No Abstract]   [Full Text] [Related]  

  • 8. [Rare diseases health plan: outcome and expectations].
    Tchernia G; Le Hénanff G; Kremp-Roussey O
    Arch Pediatr; 2010 Jun; 17(6):700-1. PubMed ID: 20654849
    [No Abstract]   [Full Text] [Related]  

  • 9. [Neuromuscular diseases are many but rare].
    Lindvall B
    Lakartidningen; 2013 Apr 10-16; 110(15):752-3. PubMed ID: 23662534
    [No Abstract]   [Full Text] [Related]  

  • 10. [Muscle weakness: differential diagnosis and assessment].
    Schwager S; Hochuli M; Jung HH
    Praxis (Bern 1994); 2010 Sep; 99(19):1121-9; quiz 1129-30. PubMed ID: 20859875
    [No Abstract]   [Full Text] [Related]  

  • 11. A National French consensus on gene lists for the diagnosis of myopathies using next-generation sequencing.
    Krahn M; Biancalana V; Cerino M; Perrin A; Michel-Calemard L; Nectoux J; Leturcq F; Bouchet-Séraphin C; Acquaviva-Bourdain C; Campana-Salort E; Molon A; Urtizberea JA; Audic F; Chabrol B; Pouget J; Froissart R; Melki J; Rendu J; Petit F; Métay C; Seta N; Sternberg D; Fauré J; Cossée M
    Eur J Hum Genet; 2019 Mar; 27(3):349-352. PubMed ID: 30552423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bibliography. Current world literature. Neuromuscular diseases: muscle.
    Curr Opin Neurol; 1999 Oct; 12(5):631-44. PubMed ID: 10590901
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ptosis in rare muscle and neuromuscular junction disorders: A literature review and diagnostic flowchart].
    Brignol TN; Urtizberea JA
    J Fr Ophtalmol; 2015 Dec; 38(10):e253-4. PubMed ID: 26584773
    [No Abstract]   [Full Text] [Related]  

  • 14. [Differential diagnosis of thyrotoxic myopathy].
    Kazakov VM
    Klin Med (Mosk); 1991 Jan; 69(1):107-11. PubMed ID: 2023385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rare diseases -- a transnational dermatological perspective].
    Laimer M
    J Dtsch Dermatol Ges; 2014 Apr; 12(4):367-8. PubMed ID: 24698597
    [No Abstract]   [Full Text] [Related]  

  • 16. [Patient demographics and evaluation of examinations in a neuromuscular clinic over a three-year period].
    Anthonisen M; Toft R; Rønager J; Vissing J
    Ugeskr Laeger; 2005 May; 167(22):2405-8. PubMed ID: 15987032
    [No Abstract]   [Full Text] [Related]  

  • 17. [Closing conference of the 1st day: Fighting against rare diseases: a priority for Eurobiomed, Biocluster of Southern, France].
    Berthe J; Fourcade B; Pastor G; Le Dain AY; Kremp O
    Presse Med; 2012 May; 41 Suppl 1():S20-2. PubMed ID: 22480853
    [No Abstract]   [Full Text] [Related]  

  • 18. [Together for patients with hereditary neuromuscular conditions].
    Arntzen KA; Lund I; Rasmussen M; Rønningen KE; Torp TI; Ørstavik K
    Tidsskr Nor Laegeforen; 2016 Aug; 136(14-15):1198-9. PubMed ID: 27554555
    [No Abstract]   [Full Text] [Related]  

  • 19. [Psycho-neuromuscular symptoms due to endocrine diseases].
    Kamijo K
    Nihon Naika Gakkai Zasshi; 1998 Jun; 87(6):1053-8. PubMed ID: 9702017
    [No Abstract]   [Full Text] [Related]  

  • 20. [Electromyography and diagnosis of muscular diseases].
    Colding-Jørgensen E
    Ugeskr Laeger; 2005 Aug; 167(33):3070; author reply 3070-2. PubMed ID: 16109264
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.